Bank of America’s Cyclo Therapeutics, Inc. Warrant CYTHW Stock Holding History
Bought
Maintained
Sold
Bank of America's CYTHW Position: Q1 2025 in Review
Bank of America sold out of Cyclo Therapeutics, Inc. Warrant (CYTHW) in Q1 2025, closing a stake of 160 shares — an estimated $12 sold.
Bank of America first reported a position in CYTHW in Q3 2024 and held it in 2 quarters. The position peaked at $19 in Q3 2024. 0 funds tracked by Wall St. Rank hold CYTHW as of Q1 2025.
- Bank of America reported no remaining Cyclo Therapeutics, Inc. Warrant position as of Q1 2025 after selling out during the quarter.
- Bank of America sold 160 Cyclo Therapeutics, Inc. Warrant shares in Q1 2025, an estimated $12.
- Bank of America first reported a position in Cyclo Therapeutics, Inc. Warrant in Q3 2024 and held it in 2 quarters.
- Bank of America's Cyclo Therapeutics, Inc. Warrant position peaked at $19 in Q3 2024.
- 0 funds tracked by Wall St. Rank held Cyclo Therapeutics, Inc. Warrant as of Q1 2025.
Based on Bank of America's 13F filing for Q1 2025, filed 15 May 2025.